Long-term effects of strontium ranelate on knee osteoarthritis symptoms: a two year prospective, randomised, placebo-controlled study
Phase of Trial: Phase III
Latest Information Update: 26 Dec 2017
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 27 Nov 2012 Actual end date changed from 30 Jun 2009 to 30 Dec 2009 as reported by ISRCTN.
- 18 Jun 2007 New trial record.